Religare Enterprises Q3 FY26 earnings call: Revenue & Margins
Q3 FY26 earnings call: what management said on revenue, margins and capex.
- Revenue
- ₹2,056Cr
- +23.3% YoY
- −1% QoQ
- Net profit
- −₹77Cr
- Q3 FY25: −₹63 Cr
- Margin
- −4.6%
- −0.9 pp YoY
- −7.8 pp QoQ
Guidance rank: #23 of 67 in Finance
See the sector's top 10 — free with your mobile number.
The short version
Insurance Business (Care Health Insurance): - Retail business grew by 41% YoY on a full premium basis in the recent quarter. Care Health Insurance shows strong growth with retail premium growth at 41% YoY on full premium basis.
From Religare Enterprises Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Insurance Business (Care Health Insurance):
- Retail business grew by 41% YoY on a full premium basis in the recent quarter.
- Market share in retail health insurance continues to expand, currently 11.4% of the industry.
- Full premium basis growth for the current year at 21.5%.
- Focus on digital transformation, improving efficiency and customer experience.
- Financial Services (Religare Finvest and Broking):
- Reorganization and demerger expected to unlock value and enable focused growth.
- Lending business yet to restart fully; sufficient capital to fuel growth once ramp-up begins.
- Broking business revenues grew 12% YoY; significant increase in client debit book (93% YoY).
- Plans to expand lending and broking with new leadership hires targeting multifold franchise growth.
- Overall:
2 more points from Religare Enterprises Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Religare Enterprises Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Post capital infusion of INR600 crores (INR250 crores already infused in Care Health Insurance), Religare aims to maintain solvency margin at 1.7 or above.
- Additional capital raising options include raising subordinated debt up to INR1,000 crores.
- Out of the INR1,500 crores raised via warrants, INR410 crores has been received so far; INR256 crores infused in CARE, rest allocated to subsidiaries including broking and housing.
- Plans to leverage financial services subsidiaries further from their current unleveraged position (e.g., Religare Finvest sitting on INR500 crores cash).
- INR250 crores infusion planned in housing finance to start leveraging and expanding franchise.
2 more points from Religare Enterprises Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Finance
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Religare Enterprises Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Religare Enterprises Ltd said on order book & pipeline — free account, 30 seconds.
Religare Enterprises Ltd — Quarterly revenue & net profit
Religare Enterprises Ltd Q3 FY26 results — key figures
| ₹ Cr | Q3 FY26 | Q3 FY25 | YoY | Q2 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 2,056 | 1,668 | +23.3% | 2,077 | -1% |
| Operating profit (EBITDA) | -95 | -61 | — | 67 | -241.8% |
| Operating margin | -4.6% | -3.7% | -0.9 pp | 3.2% | -7.8 pp |
| Profit before tax | -103 | -79 | — | 57 | -280.7% |
| Net profit (PAT) | -77 | -63 | — | 46 | -267.4% |
| EPS (₹) | -1.36 | -1.30 | — | 1.17 | -216.2% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹2.4K Cr, net loss ₹98 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Religare Enterprises's management said in earlier quarters
Others in Finance this season
- Jio Financial (Q3 FY26)
Phase 2 capex includes ~₹110 crore investment in Uttar Pradesh for: . Key concall takeaways from Jio Financial Services Ltd's Q3 FY26 earnings call — and how…
- Capital Trust (Q3 FY26)
Total Income for Q3 FY26: ₹11.3 Crores . Key investor presentation takeaways from Capital Trust Ltd's Q3 FY26 investor presentation — and how it ranks against s
- CSL Finance (Q3 FY26)
Q3FY26 revenue was ₹64.44 crore, up 20% YoY from ₹53.70 crore in Q3FY25 (Page 8). Key investor presentation takeaways from CSL Finance's Q3 FY26 investor presen
- SRG Housing (Q3 FY26)
130.60 crore (up from Rs. Key investor presentation takeaways from SRG Housing Finance Ltd's Q3 FY26 investor presentation — and how it ranks against sector pee
Potential multibaggers · Q2 FY27
Potential multibaggers in Finance
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Religare Enterprises Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Religare Enterprises Ltd Q3 FY26 results?
Insurance Business (Care Health Insurance): - Retail business grew by 41% YoY on a full premium basis in the recent quarter. Care Health Insurance shows strong growth with retail premium growth at 41% YoY on full premium basis.
What is Religare Enterprises Ltd share price analysis?
Religare Enterprises Ltd currently shows a neutral. The stock trades at a P/E of 99.6 with a market cap of ₹8,562 Cr. Investors should review the full earnings analysis for detailed insights.
Is Religare Enterprises Ltd planning capital expenditure?
Post capital infusion of INR600 crores (INR250 crores already infused in Care Health Insurance), Religare aims to maintain solvency margin at 1.7 or above.
Keep Religare Enterprises Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
